首页 > 最新文献

Journal of B.U.ON. : official journal of the Balkan Union of Oncology最新文献

英文 中文
3D laparoscopic salvage radical prostatectomy: mini-series report and review of the literature. 三维腹腔镜根治性前列腺切除术:迷你系列报告和文献回顾。
Vlad Horia Schitcu, Mira Florea, Nucu Alexandru Marica, Ioan-Catalin Vlad, Ion Cojocaru, Vlad Munteanu, Paul Kubelac, Mihnea Bogdan Borz

Purpose: Salvage therapy represents a rescue therapy, given after the first line of treatment had failed.The purpose of this study was to review the outcomes of patients who underwent salvage laparoscopic radical prostatectomy (sLRP) in our department and to review current published studies.

Methods: Our mini-series consisted of 6 patients with recurrent prostate cancer(PCa) after non-surgical primary treatment. All interventions were performed by a single surgeon from the Oncological Institute "Prof. Dr. Ion Chiricuta" Cluj Napoca, Romania.A literature review was carried out in June 2020 using the PubMed and MEDLINE databases to identify relevant studies published in the literature between 2000 and 2020. Six papers were selected for our review.We reviewed the oncological and functional outcomes of patients that underwent sLRP.

Results: Extraperitoneal sLRP was performed in 6 patients. Biochemical failure after primary treatment developed between one and five years. Mean operative time was 135.5 min, mean blood loss was 328 ml. No intraoperative complications occurred and no conversions to open surgery. R0 was achieved in 5 out of the 6 patients (83.5%). Out of the 6 patients 2 are incontinent.

Conclusions: SLRP remains an underused procedure and a missed therapeutic opportunity for selected patients. From published data and personal experience, we conclude that in experienced hands sLRP for localized prostate cancer is a feasible, safe and efficient method to treat recurrent PCa. Short-term oncological outcomes are optimistic but further studies need to be made to observe the long-term outcomes.

目的:抢救性治疗是指在第一线治疗失败后进行的抢救性治疗。本研究的目的是回顾在我科接受挽救性腹腔镜前列腺根治术(sLRP)的患者的结果,并回顾目前已发表的研究。方法:我们的迷你系列包括6例经非手术治疗的复发性前列腺癌症(PCa)患者。所有干预措施均由罗马尼亚Cluj Napoca肿瘤研究所“Ion Chiricuta教授博士”的一名外科医生进行。2020年6月,使用PubMed和MEDLINE数据库进行了文献综述,以确定2000年至2020年间发表在文献中的相关研究。我们挑选了六篇论文进行审查。我们回顾了接受sLRP的患者的肿瘤学和功能结果。结果:6例患者行腹膜外sLRP。初次治疗后的生化衰竭发生在一到五年之间。平均手术时间为135.5分钟,平均失血量为328毫升。没有发生术中并发症,也没有转为开放手术。6例患者中有5例(83.5%)达到R0,其中2例大小便失禁。结论:对于选定的患者来说,SLRP仍然是一种未充分利用的手术,也是一种错失的治疗机会。根据已发表的数据和个人经验,我们得出结论,在经验丰富的人手中,sLRP治疗局限性前列腺癌症是一种可行、安全和有效的治疗复发性前列腺癌的方法。短期肿瘤学结果是乐观的,但需要进行进一步的研究来观察长期结果。
{"title":"3D laparoscopic salvage radical prostatectomy: mini-series report and review of the literature.","authors":"Vlad Horia Schitcu, Mira Florea, Nucu Alexandru Marica, Ioan-Catalin Vlad, Ion Cojocaru, Vlad Munteanu, Paul Kubelac, Mihnea Bogdan Borz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Salvage therapy represents a rescue therapy, given after the first line of treatment had failed.The purpose of this study was to review the outcomes of patients who underwent salvage laparoscopic radical prostatectomy (sLRP) in our department and to review current published studies.</p><p><strong>Methods: </strong>Our mini-series consisted of 6 patients with recurrent prostate cancer(PCa) after non-surgical primary treatment. All interventions were performed by a single surgeon from the Oncological Institute \"Prof. Dr. Ion Chiricuta\" Cluj Napoca, Romania.A literature review was carried out in June 2020 using the PubMed and MEDLINE databases to identify relevant studies published in the literature between 2000 and 2020. Six papers were selected for our review.We reviewed the oncological and functional outcomes of patients that underwent sLRP.</p><p><strong>Results: </strong>Extraperitoneal sLRP was performed in 6 patients. Biochemical failure after primary treatment developed between one and five years. Mean operative time was 135.5 min, mean blood loss was 328 ml. No intraoperative complications occurred and no conversions to open surgery. R0 was achieved in 5 out of the 6 patients (83.5%). Out of the 6 patients 2 are incontinent.</p><p><strong>Conclusions: </strong>SLRP remains an underused procedure and a missed therapeutic opportunity for selected patients. From published data and personal experience, we conclude that in experienced hands sLRP for localized prostate cancer is a feasible, safe and efficient method to treat recurrent PCa. Short-term oncological outcomes are optimistic but further studies need to be made to observe the long-term outcomes.</p>","PeriodicalId":94065,"journal":{"name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","volume":"26 3","pages":"964-969"},"PeriodicalIF":0.0,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type. 子宫内膜样癌和非子宫内膜样癌高级别子宫内膜癌的错配修复状态。
Triada Doulgeraki, Stylianos Vagios, Evangelia Kavoura, Petros Yiannou, Irini Messini, Afroditi Nonni, Christos Papadimitriou, Athanassios Vlachos, Kitty Pavlakis

Purpose: To evaluate mismatch repair (MMR) status in a series of high-grade endometrial carcinomas and correlate it with several clinicopathological characteristics and with survival.

Methods: One hundred and one patients with high-grade endometrial carcinoma, both of endometrioid and of non-endometrioid type were included in the study. The expression of MLH1, MSH2, MSH6 and PMS2 was evaluated by immunohistochemistry.

Results: In our cohort, 41 women had an endometrioid and 60 women a non-endometrioid carcinoma. Endometrioid histotype was statistically more frequent in deficient MMR (dMMR) tumors (73.3%), while non-endometrioid carcinomas in proficient (pMMR) cases (73.8%) (p<0.001). When analyzing the group of endometrioid and non-endometrioid carcinomas separately, only dMMR endometrioid cancers were found to be statistically related to deep myometrial invasion, lymph-node metastases and advanced stage (p=0.035, p=0.011 and p=0.028, respectively). Univariate and multivariate analysis revealed no relation between MMR status and progression-free survival (PFS) or overall survival (OS). Adjuvant treatment was not found to influence the course of the disease. When MMR proteins were studied separately, MLH1/PMS2 loss was related to deep myometrial invasion (p=0.019 and p=0.036, respectively) and MSH6 loss to lymph-node metastases (p=0.04).

Conclusions: In our group of high-grade endometrial carcinomas, MMR deficiency was statistically more frequent in endometrioid than in non-endometrioid cancers. Furthermore, only dMMR endometrioid type grade 3 carcinomas were found to be related with features indicative of aggressive behavior. Considering some unique relation of each MMR protein with distinct clinicopathological features, the assessment of all four proteins is proposed.

目的:评估一系列高级别子宫内膜癌的错配修复(MMR)状态,并将其与一些临床病理特征和生存率相关联:研究纳入了 101 例高级别子宫内膜癌(包括子宫内膜样癌和非子宫内膜样癌)患者。免疫组化法评估了 MLH1、MSH2、MSH6 和 PMS2 的表达:结果:在我们的队列中,41 名妇女患有子宫内膜样癌,60 名妇女患有非子宫内膜样癌。据统计,子宫内膜样组织型在缺乏 MMR(dMMR)的肿瘤中更为常见(73.3%),而非子宫内膜样癌则在精通 MMR(pMMR)的病例中占 73.8%(p 结论:在我们的这组高级别子宫内膜癌患者中,子宫内膜样组织型在缺乏 MMR(dMMR)的肿瘤中更为常见(73.3%):在我们这组高级别子宫内膜癌中,据统计,子宫内膜样癌中 MMR 缺乏的发生率高于非子宫内膜样癌。此外,只有 dMMR 子宫内膜样 3 级癌与侵袭性特征有关。考虑到每种 MMR 蛋白与不同临床病理特征的独特关系,建议对所有四种蛋白进行评估。
{"title":"Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type.","authors":"Triada Doulgeraki, Stylianos Vagios, Evangelia Kavoura, Petros Yiannou, Irini Messini, Afroditi Nonni, Christos Papadimitriou, Athanassios Vlachos, Kitty Pavlakis","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate mismatch repair (MMR) status in a series of high-grade endometrial carcinomas and correlate it with several clinicopathological characteristics and with survival.</p><p><strong>Methods: </strong>One hundred and one patients with high-grade endometrial carcinoma, both of endometrioid and of non-endometrioid type were included in the study. The expression of MLH1, MSH2, MSH6 and PMS2 was evaluated by immunohistochemistry.</p><p><strong>Results: </strong>In our cohort, 41 women had an endometrioid and 60 women a non-endometrioid carcinoma. Endometrioid histotype was statistically more frequent in deficient MMR (dMMR) tumors (73.3%), while non-endometrioid carcinomas in proficient (pMMR) cases (73.8%) (p<0.001). When analyzing the group of endometrioid and non-endometrioid carcinomas separately, only dMMR endometrioid cancers were found to be statistically related to deep myometrial invasion, lymph-node metastases and advanced stage (p=0.035, p=0.011 and p=0.028, respectively). Univariate and multivariate analysis revealed no relation between MMR status and progression-free survival (PFS) or overall survival (OS). Adjuvant treatment was not found to influence the course of the disease. When MMR proteins were studied separately, MLH1/PMS2 loss was related to deep myometrial invasion (p=0.019 and p=0.036, respectively) and MSH6 loss to lymph-node metastases (p=0.04).</p><p><strong>Conclusions: </strong>In our group of high-grade endometrial carcinomas, MMR deficiency was statistically more frequent in endometrioid than in non-endometrioid cancers. Furthermore, only dMMR endometrioid type grade 3 carcinomas were found to be related with features indicative of aggressive behavior. Considering some unique relation of each MMR protein with distinct clinicopathological features, the assessment of all four proteins is proposed.</p>","PeriodicalId":94065,"journal":{"name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","volume":"24 5","pages":"2020-2027"},"PeriodicalIF":0.0,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141478257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion. 芒果苷植物化学物质对吉西他滨耐药胰腺癌癌细胞生长的抑制作用涉及诱导自噬、内源性 ROS 生成、细胞周期破坏、线粒体介导的细胞凋亡以及抑制癌细胞迁移和侵袭。
Lei Yu, Min Chen, Rui Zhang, Zhaohui Jin

Purpose: Pancreatic cancer causes considerable mortality across the globe and the treatment options for pancreatic cancer are limited. Besides, the development of drug resistance among the pancreatic cancer cells makes it even difficult to manage. In this study the anticancer effects of mangiferin were examined against the Mia-PaCa2 gemcitabine-resistant pancreatic cancer cells.

Materials/methods: Cell proliferation was examined by MTT assay while as apoptosis was detected by fluorescent microscopy and western blot. Effects on cell cycle, reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) were evaluated by flow cytometry. The fact that mangiferin induced autophagy was demonstrated by fluorescent microscopy in combination with western blot method.

Results: The results revealed that mangiferin inhibited the growth of the Mia-PaCa2 cells and exhibited an IC50 of 10 µM. Nonetheless, the toxic effects of mangiferin were less on the normal cells. Mangiferin induces apoptosis in the Mia-PaCa2 cells which was associated with enhancement of Bax/Bcl-2 ratio. Further investigations revealed that mangiferin triggered autophagy in the Mia-PaCa2 cells as evident from the elevated expressions of the LC3 II and Beclin-1. The antiproliferative effects of mangiferin were also accompanied by the generation of endogenous ROS and cell cycle arrest. Investigation of the effects of mangiferin on the invasion and migration of the Mia-PaCa2 cells showed that mangiferin suppressed the migration and invasion potential of the Mia-PaCa2 cells.

Conclusions: These findings suggest that mangiferin could be utilised for the development of chemotherapy for pancreatic cancer provided further in depth experiments are carried out along with its toxicological studies.

目的:胰腺癌在全球造成的死亡率相当高,而胰腺癌的治疗方法却很有限。此外,胰腺癌细胞耐药性的产生使其更加难以控制。本研究考察了芒果苷对 Mia-PaCa2 吉西他滨耐药胰腺癌细胞的抗癌作用:材料/方法: 细胞增殖由 MTT 法检测,细胞凋亡由荧光显微镜和 Western 印迹法检测。流式细胞术评估了芒果苷对细胞周期、活性氧(ROS)生成和线粒体膜电位(MMP)的影响。荧光显微镜结合 Western 印迹法证明了芒果苷诱导自噬的事实:结果表明,芒果苷能抑制 Mia-PaCa2 细胞的生长,其 IC50 值为 10 µM。然而,芒果苷对正常细胞的毒性作用较小。芒果苷能诱导 Mia-PaCa2 细胞凋亡,这与 Bax/Bcl-2 比率的提高有关。进一步研究发现,从 LC3 II 和 Beclin-1 表达的升高可以看出,芒果苷能引发 Mia-PaCa2 细胞的自噬。芒果苷的抗增殖作用还伴随着内源性 ROS 的产生和细胞周期的停滞。芒果苷对Mia-PaCa2细胞侵袭和迁移影响的研究表明,芒果苷抑制了Mia-PaCa2细胞的迁移和侵袭潜力:这些研究结果表明,只要进一步开展深入实验和毒理学研究,芒果苷可用于开发胰腺癌化疗药物。
{"title":"Inhibition of cancer cell growth in gemcitabine-resistant pancreatic carcinoma by mangiferin phytochemical involves induction of autophagy, endogenous ROS production, cell cycle disruption, mitochondrial mediated apoptosis and suppression of cancer cell migration and invasion.","authors":"Lei Yu, Min Chen, Rui Zhang, Zhaohui Jin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Pancreatic cancer causes considerable mortality across the globe and the treatment options for pancreatic cancer are limited. Besides, the development of drug resistance among the pancreatic cancer cells makes it even difficult to manage. In this study the anticancer effects of mangiferin were examined against the Mia-PaCa2 gemcitabine-resistant pancreatic cancer cells.</p><p><strong>Materials/methods: </strong>Cell proliferation was examined by MTT assay while as apoptosis was detected by fluorescent microscopy and western blot. Effects on cell cycle, reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) were evaluated by flow cytometry. The fact that mangiferin induced autophagy was demonstrated by fluorescent microscopy in combination with western blot method.</p><p><strong>Results: </strong>The results revealed that mangiferin inhibited the growth of the Mia-PaCa2 cells and exhibited an IC50 of 10 µM. Nonetheless, the toxic effects of mangiferin were less on the normal cells. Mangiferin induces apoptosis in the Mia-PaCa2 cells which was associated with enhancement of Bax/Bcl-2 ratio. Further investigations revealed that mangiferin triggered autophagy in the Mia-PaCa2 cells as evident from the elevated expressions of the LC3 II and Beclin-1. The antiproliferative effects of mangiferin were also accompanied by the generation of endogenous ROS and cell cycle arrest. Investigation of the effects of mangiferin on the invasion and migration of the Mia-PaCa2 cells showed that mangiferin suppressed the migration and invasion potential of the Mia-PaCa2 cells.</p><p><strong>Conclusions: </strong>These findings suggest that mangiferin could be utilised for the development of chemotherapy for pancreatic cancer provided further in depth experiments are carried out along with its toxicological studies.</p>","PeriodicalId":94065,"journal":{"name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","volume":"24 4","pages":"1581-1586"},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138815355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of miR-489 in the proliferation and apoptosis of pancreatic carcinoma. miR-489 在胰腺癌增殖和凋亡中的作用
Maolan Zeng, Yanhua Zhou, Yinxia Zhang, Tiancheng Wang, Jing Wang

Purpose: The purpose of the present study was to detect the expression of miR-489 in pancreatic cancer (PC) tissues and cells, and to explore the effects of miR-489 on cell proliferation and apoptosis of human PC cells and to also uncover the underlying mechanism.

Methods: miR-489 expression was assessed by quantitative real time-polymerase chain reaction (qRT-PCR) in PC tissues and PANC-1 and HPDE6-C7 cell lines. The binding-site predictions by bioinformatics showed that AKT Serine/Threonine Kinase 3 (AKT3) might be a potential target of miR-489. AKT3 expression in PC tissues and cells was detected by qRT-PCR, luciferase report assay and Western blotting assay were used to verify the rationality of the target gene. The biological role of miR-489 on cell proliferation, cell cycle and apoptosis were determined in PANC-1 cells by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay and flow cytometry after transfection with miR-NC, miR-489 mimics and si-AKT3.

Results: Compared with normal adjacent tissues and normal pancreatic cells, the expression of miR-489 was markedly down-regulated in PC tissues and cells. AKT3 was considered as a downstream gene of miR-489 and it was found that the expression levels of miR-489 and AKT3 were inversely proportional to each other, which was further confirmed by luciferase and Western blot assays. In subsequent experiments, up-regulation of miR-489 by transfection with miR-489 mimics significantly inhibited cell proliferation, blocked the G1/S transition and induced cell apoptosis of PANC-1 cells. However, overexpression of AKT3 significantly counteracted the biological effects of miR-489.

Conclusions: Our findings indicate that up-regulation of miR-489 could suppress PC cell proliferation and facilitate cell apoptosis through targeting AKT3. miR-489 and AKT3 might serve as potential targets in the therapy of PC.

目的:本研究旨在检测miR-489在胰腺癌(PC)组织和细胞中的表达,探讨miR-489对人PC细胞增殖和凋亡的影响,并揭示其潜在机制。方法:采用实时聚合酶链反应(qRT-PCR)定量评估miR-489在PC组织、PANC-1和HPDE6-C7细胞系中的表达。生物信息学的结合位点预测表明,AKT丝氨酸/苏氨酸激酶3(AKT3)可能是miR-489的潜在靶点。通过 qRT-PCR 检测了 AKT3 在 PC 组织和细胞中的表达,荧光素酶报告实验和 Western 印迹实验验证了靶基因的合理性。转染 miR-NC、miR-489 mimics 和 si-AKT3 后,用 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)测定法和流式细胞术检测了 miR-489 对 PANC-1 细胞增殖、细胞周期和细胞凋亡的生物学作用:结果:与正常邻近组织和正常胰腺细胞相比,miR-489 在 PC 组织和细胞中的表达明显下调。AKT3被认为是miR-489的下游基因,研究发现miR-489和AKT3的表达水平成反比,荧光素酶和Western印迹检测进一步证实了这一点。在随后的实验中,通过转染 miR-489 mimics 上调 miR-489 能显著抑制 PANC-1 细胞的增殖、阻断 G1/S 转换并诱导细胞凋亡。然而,过表达 AKT3 能明显抵消 miR-489 的生物效应:我们的研究结果表明,miR-489的上调可通过靶向AKT3抑制PC细胞增殖并促进细胞凋亡。
{"title":"Role of miR-489 in the proliferation and apoptosis of pancreatic carcinoma.","authors":"Maolan Zeng, Yanhua Zhou, Yinxia Zhang, Tiancheng Wang, Jing Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the present study was to detect the expression of miR-489 in pancreatic cancer (PC) tissues and cells, and to explore the effects of miR-489 on cell proliferation and apoptosis of human PC cells and to also uncover the underlying mechanism.</p><p><strong>Methods: </strong>miR-489 expression was assessed by quantitative real time-polymerase chain reaction (qRT-PCR) in PC tissues and PANC-1 and HPDE6-C7 cell lines. The binding-site predictions by bioinformatics showed that AKT Serine/Threonine Kinase 3 (AKT3) might be a potential target of miR-489. AKT3 expression in PC tissues and cells was detected by qRT-PCR, luciferase report assay and Western blotting assay were used to verify the rationality of the target gene. The biological role of miR-489 on cell proliferation, cell cycle and apoptosis were determined in PANC-1 cells by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay and flow cytometry after transfection with miR-NC, miR-489 mimics and si-AKT3.</p><p><strong>Results: </strong>Compared with normal adjacent tissues and normal pancreatic cells, the expression of miR-489 was markedly down-regulated in PC tissues and cells. AKT3 was considered as a downstream gene of miR-489 and it was found that the expression levels of miR-489 and AKT3 were inversely proportional to each other, which was further confirmed by luciferase and Western blot assays. In subsequent experiments, up-regulation of miR-489 by transfection with miR-489 mimics significantly inhibited cell proliferation, blocked the G1/S transition and induced cell apoptosis of PANC-1 cells. However, overexpression of AKT3 significantly counteracted the biological effects of miR-489.</p><p><strong>Conclusions: </strong>Our findings indicate that up-regulation of miR-489 could suppress PC cell proliferation and facilitate cell apoptosis through targeting AKT3. miR-489 and AKT3 might serve as potential targets in the therapy of PC.</p>","PeriodicalId":94065,"journal":{"name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","volume":"24 4","pages":"1574-1580"},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138815358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginseng and cancer. 人参与癌症
Ahmet Unlu, Erdinc Nayir, Onder Kirca, Hale Ay, Mustafa Ozdogan

Derived from the Greek word Panacea that means 'cure for all', Ginseng (Panax) has had an important place in Chinese Medicine for many of years. As the name suggests, it is believed to be a miraculous plant effective in the treatment of many health problems. It is claimed to have many effects such as sedative, hypnotic, aphrodisiac, antidepressant, diuretic, and stimulating effects, and to be effective in the treatment of certain health problems such as diabetes, Alzheimer's disease, erectile dysfunction and infections. In addition, its effects on the prevention and treatment of cancer as well as on the reduction of cancer-related symptoms have been prioritized in recent years. However, the studies that have been done so far do not confirm these effects. Although certain favorable results have been obtained in some studies intended for investigating its effects on acute nasopharyngitis, diabetes, Alzheimer's disease, and erectile dysfunction, it is early to say anything conclusive. And in cancer patients, it has been shown to be effective in reducing weakness due to cancer and its treatment. On the other hand, ginseng may cause important drug interactions, although it is described as a relatively safe product. For now, it seems to be reasonable to use ginseng only for cancer-related weakness in cancer patients at this point. But this should definitely be done within the knowledge and under the control of oncologists.

人参(三七)源于希腊语 Panacea,意为 "包治百病",多年来一直在中医学中占有重要地位。顾名思义,人们认为人参是一种神奇的植物,能有效治疗许多健康问题。据称,三七具有镇静、催眠、壮阳、抗抑郁、利尿和刺激作用,对治疗糖尿病、老年痴呆症、勃起功能障碍和感染等某些健康问题有效。此外,它在预防和治疗癌症以及减轻癌症相关症状方面的作用近年来也被列为重点研究对象。然而,迄今为止所做的研究并未证实这些作用。虽然在一些旨在研究其对急性鼻咽炎、糖尿病、老年痴呆症和勃起功能障碍的影响的研究中取得了一些有利的结果,但要下定论还为时尚早。在癌症患者中,它已被证明能有效减轻因癌症及其治疗而导致的虚弱。另一方面,人参可能会引起重要的药物相互作用,尽管它被描述为一种相对安全的产品。就目前而言,将人参用于癌症患者的癌症相关虚弱症状似乎是合理的。但这绝对应该在肿瘤专家的知情和控制下进行。
{"title":"Ginseng and cancer.","authors":"Ahmet Unlu, Erdinc Nayir, Onder Kirca, Hale Ay, Mustafa Ozdogan","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Derived from the Greek word Panacea that means 'cure for all', Ginseng (Panax) has had an important place in Chinese Medicine for many of years. As the name suggests, it is believed to be a miraculous plant effective in the treatment of many health problems. It is claimed to have many effects such as sedative, hypnotic, aphrodisiac, antidepressant, diuretic, and stimulating effects, and to be effective in the treatment of certain health problems such as diabetes, Alzheimer's disease, erectile dysfunction and infections. In addition, its effects on the prevention and treatment of cancer as well as on the reduction of cancer-related symptoms have been prioritized in recent years. However, the studies that have been done so far do not confirm these effects. Although certain favorable results have been obtained in some studies intended for investigating its effects on acute nasopharyngitis, diabetes, Alzheimer's disease, and erectile dysfunction, it is early to say anything conclusive. And in cancer patients, it has been shown to be effective in reducing weakness due to cancer and its treatment. On the other hand, ginseng may cause important drug interactions, although it is described as a relatively safe product. For now, it seems to be reasonable to use ginseng only for cancer-related weakness in cancer patients at this point. But this should definitely be done within the knowledge and under the control of oncologists.</p>","PeriodicalId":94065,"journal":{"name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","volume":"21 6","pages":"1383-1387"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138815352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience. 胰腺癌根治性胰十二指肠切除术后的预后指标:对单中心经验的回顾性多变量分析。
Athanasios Petrou, Zahir Soonawalla, Michael-Antony Silva, Antonio Manzelli, Demetrios Moris, Patric-Paul Tabet, Peter Friend

Purpose: Survival after curative resection of pancreatic, ampullary and lower common bile duct cancer remains very poor. The aim of this study was to assess important prognostic factors in patients with resectable pancreatic cancer.

Methods: From 2006 to 2010, 156 patients underwent pancreatoduodenectomy (PD) for malignancies of pancreatic, ampullary or lower common bile duct in our institution. Based on the inclusion criteria 101 patients were selected in our retrospective statistical analysis. Of these 101 cases of malignancies, 65.4% were located in the pancreatic head, 18.8% in the ampulla and 15.8% in the lower bile duct. 48.5% of patients underwent classical PD, and 51.5% pylorus-preserving pancreatoduodenectomy (PPPD). Clinical and pathological data were collected, Kaplan-Meier method and Cox proportional hazard models were used to evaluate prognostic factors.

Results: Multivariate analysis revealed that blood transfusion, vascular invasion, T4 vs T1 stage, and R0 resection margins were significant negative predictors of survival. Conversely, ampullary (vs pancreatic ductal) and adjuvant chemotherapy were significantly associated with longer survival. Lymph node ratio (LNR), in all its forms, was not found to have a significant effect on survival. For all patients, tumor grading (p=0.042), resection margins (p=0.004), T stage (p=0.001), perineural invasion (p=0.029), vascular invasion (p=0.007) and age >65 years (p=0.009) were factors that impacted survival.

Conclusion: Surgical resection margins, tumor grade, T stage, perineural invasion, vascular invasion, age >65 and adjuvant chemotherapy are the strongest predictors of survival after surgical resection of pancreatic, ampullary and lower common bile duct cancer. In this series, lymph node ratio did not impact survival.

目的:胰腺癌、胰壶腹癌和胆总管下段癌根治性切除术后的生存率仍然很低。本研究旨在评估可切除胰腺癌患者的重要预后因素:2006年至2010年,我院共有156名患者因胰腺、胰壶腹部或胆总管下端恶性肿瘤接受了胰十二指肠切除术(PD)。根据纳入标准,我们选择了 101 例患者进行回顾性统计分析。在这101例恶性肿瘤中,65.4%位于胰头,18.8%位于胰管,15.8%位于胆总管下端。48.5%的患者接受了传统的胰十二指肠切除术,51.5%的患者接受了保留幽门的胰十二指肠切除术(PPPD)。收集了临床和病理数据,采用卡普兰-梅耶法和考克斯比例危险模型评估预后因素:结果:多变量分析显示,输血、血管侵犯、T4与T1分期、R0切除边缘是生存率的显著负预测因素。相反,胰腺(与胰腺导管)和辅助化疗与延长生存期有显著相关性。各种形式的淋巴结比(LNR)对生存率均无明显影响。在所有患者中,肿瘤分级(p=0.042)、切除边缘(p=0.004)、T期(p=0.001)、神经周围侵犯(p=0.029)、血管侵犯(p=0.007)和年龄大于65岁(p=0.009)是影响生存率的因素:结论:手术切除边缘、肿瘤分级、T分期、神经周围浸润、血管浸润、年龄大于65岁和辅助化疗是胰腺癌、胰瓿癌和胆总管下段癌手术切除后生存率的最强预测因素。在该系列研究中,淋巴结比例对生存率没有影响。
{"title":"Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.","authors":"Athanasios Petrou, Zahir Soonawalla, Michael-Antony Silva, Antonio Manzelli, Demetrios Moris, Patric-Paul Tabet, Peter Friend","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Survival after curative resection of pancreatic, ampullary and lower common bile duct cancer remains very poor. The aim of this study was to assess important prognostic factors in patients with resectable pancreatic cancer.</p><p><strong>Methods: </strong>From 2006 to 2010, 156 patients underwent pancreatoduodenectomy (PD) for malignancies of pancreatic, ampullary or lower common bile duct in our institution. Based on the inclusion criteria 101 patients were selected in our retrospective statistical analysis. Of these 101 cases of malignancies, 65.4% were located in the pancreatic head, 18.8% in the ampulla and 15.8% in the lower bile duct. 48.5% of patients underwent classical PD, and 51.5% pylorus-preserving pancreatoduodenectomy (PPPD). Clinical and pathological data were collected, Kaplan-Meier method and Cox proportional hazard models were used to evaluate prognostic factors.</p><p><strong>Results: </strong>Multivariate analysis revealed that blood transfusion, vascular invasion, T4 vs T1 stage, and R0 resection margins were significant negative predictors of survival. Conversely, ampullary (vs pancreatic ductal) and adjuvant chemotherapy were significantly associated with longer survival. Lymph node ratio (LNR), in all its forms, was not found to have a significant effect on survival. For all patients, tumor grading (p=0.042), resection margins (p=0.004), T stage (p=0.001), perineural invasion (p=0.029), vascular invasion (p=0.007) and age >65 years (p=0.009) were factors that impacted survival.</p><p><strong>Conclusion: </strong>Surgical resection margins, tumor grade, T stage, perineural invasion, vascular invasion, age >65 and adjuvant chemotherapy are the strongest predictors of survival after surgical resection of pancreatic, ampullary and lower common bile duct cancer. In this series, lymph node ratio did not impact survival.</p>","PeriodicalId":94065,"journal":{"name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","volume":"21 4","pages":"874-882"},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138815350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1